Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.
Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.
复制标题
DOI:
10.1007/978-3-540-37652-1_29
复制
发表时间:
1990-06
期刊:
影响因子:
56.9
通讯作者:
E. Levy;M. Carman;I. Fernandez‐Madrid;M. Power;I. Lieberburg;S. V. van Duinen;G. Bots;W. Luyendijk;B. Frangione
中科院分区:
文献类型:
--
作者:
E. Levy;M. Carman;I. Fernandez‐Madrid;M. Power;I. Lieberburg;S. V. van Duinen;G. Bots;W. Luyendijk;B. Frangione
The first cerebral amyloid molecule identified was extracted in 1983 from cerebral blood vessels obtained at autopsy from Icelandic patients who died from massive brain hemorrhages due to the deposition of cystatin C fibrils in the vessel walls (Cohen et al. 1983), a condition referred to as hereditary cerebral hemorrhage with amyloidosis (HCHWA). The importance of this study extended beyond the identification of a molecule linked to a cerebral amyloid disease: it described a novel and simple method to extract amyloid from leptomeningeal vessels, a protocol that a year later was used by G. Glenner to isolate Aβ from leptomeninges obtained from AD brains (Glenner and Wong 1984a) and has lately provided the basis to establish the relationship between amino acid substitutions and familial cerebral amyloidosis. Complete amino acid sequence analysis of the deposited cystatin C in the Icelandic cases of HCHWA revealed the first mutation associated with cerebral amyloidosis, the replacement of leucine for glutamine (Ghiso et al. 1986) due to a single A to T transversion at codon 68 (Levy et al. 1989).In 1985, shortly after the initial cystatin C and Aβreports, we received three brains from familial cases in Holland exhibiting clinico-pathological features that closely resembled the Icelandic cases, eg, recurrent episodes of cerebral hemorrhages associated with overwhelming cerebral amyloid angiopathy (CAA), features that suggested the name HCHWA-Dutch type to designate the disease. Notably, amyloid deposits were not recognized by antibodies to cystatin C but were immunoreactive with antibodies to Aβ (Fig. 1a). Whereas amino acid sequence analysis of the extracted leptomeningeal material corroborated its Aβ identity (Fig. 1e), immunohistochemical studies verified the co-existence of CAA with widespread parenchymal pre-amyloid (non-fibrillar, Congo red negative) deposits in the absence of neuritic plaques and neurofibrillary tangles. We postulated that HCHWA-Dutch type is a vascular variant of AD (van Duinen et al. 1987). Further studies revealed a point mutation at codon 693 of the APP gene, a single nucleotide transversion (G for C) resulting in the replacement of glutamate for glutamine at position 22 of the Aβ sequence (Kang et al. 1987; Levy et al. 1990; Prelli et al. 1990) and a tight linkage of the APP gene with the disease detected by restriction fragment length polymorphism (Van Broeckhoven et al. 1990). The studies with the Dutch mutation helped to establish the existence of shorter Aβ species in vascular deposits (Prelli et al. 1988), to ascertain that wild-type and mutant APP can have different phenotypic presentation and to pave the way for the discovery of the many APP nucleotide substitutions to come (described in Goate’s Chapter). In addition,